Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Adv Biomed Res ; 12: 87, 2023.
Article in English | MEDLINE | ID: mdl-37288010

ABSTRACT

Background: Cerebral palsy in children is considered a non-progressive brain injury due to abnormal brain development. The aim of this study was to investigate the effect of eight weeks of aquatic exercises on muscle strength in children with cerebral palsy. Materials and Methods: This study was performed on three boys with cerebral palsy with a mean age of 6.5 years. In this research, a single case study method with A1-B-A2 design has been used. After determining the position of the baseline, the intervention began and during 24 sessions of individual intervention, aquatic exercises were presented to the subjects and all three subjects were followed up for 2 consecutive weeks and one month after the end of the intervention. The strength of the flexor muscles of the arms and legs was measured by a power track dynamometer made by JTECK with a threshold of 4.4 N. Results: Based on the indicators of descriptive statistics and visual analysis, the intervention was effective for all three participants in muscle strength, and the strength of individuals after the intervention has improved compared to the baseline stage (percentage). Information overlap for the first and second participant in the strength of right thigh flexors was 75% and for the third participant was 100%. The strength of the upper and lower torso muscles improved after the end of the training compared to the basic stage. Conclusion: Aquatic exercises can increase the strength of children with cerebral palsy and provide a favorable environment for children with cerebral palsy.

2.
Anal Methods ; 15(16): 1985-1997, 2023 04 27.
Article in English | MEDLINE | ID: mdl-37018054

ABSTRACT

Phthalic acid esters (PAEs) are a group of organic compounds that show vulnerability effects in different stages of human development. In this work, two sensitive and efficient impedimetric biosensors (IBs) were introduced and their interactions with four PAEs, namely dibutyl phthalate (DBP), dimethyl phthalate (DMP), di(2-ethylhexyl) phthalate (DEHP), and dicyclohexyl phthalate (DCHP), in aqueous solutions with these biosensors were separately investigated via electrochemical impedance spectroscopy (EIS). The surface of a copper electrode was modified by azolla fern dried powder (AZ) and magnetite-modified azolla nanocomposites (MAZ NCs) to form an azolla-based impedimetric biosensor (AZIB) and magnetite azolla nanocomposite-based impedimetric nanobiosensor (MAZIB), respectively. Determinations of PAEs with the designed biosensors were conducted based on their blocking effect on the biosensor surface to ferrous ions oxidation. After each impedimetric measurement, the electrode surface was covered again with the modifier. Nyquist plots were obtained and indicated that the charge-transfer resistance (RCT) values of the bare electrode, AZIB, and MAZIB without injection of PAEs were 468.8, 438.7, and 285.1 kΩ, respectively. After the separate injection of DBP, DMP, DEHP, and DCHP (3 µg L-1) on the surface of AZIB and MAZIB, RCT values were obtained as 563.9, 588.5, 548.7, and 570.1 kΩ for AZIB and 878.2, 1219.2, 754.3, and 814.7 kΩ for MAZIB, respectively. It was observed that the PAE blockers with a smaller structure provided better point-by-point coverage of the surface, which led to a bigger shift in RCT. The linear relationship between the EIS responses and each PAE concentration was investigated in the range of 0.1-1000 µg L-1. The limit of detection (LOD) and limit of quantification (LOQ) values were obtained in the ranges of 0.003-0.005 µg L-1 and 0.010-0.016 µg L-1 for AZIB and 0.008-0.009 µg L-1 and 0.027-0.031 µg L-1 for MAZIB, respectively. The results showed that these biosensors can be used to determine PAEs in real aqueous samples with good relative recoveries ranging from 93.0-97.7% (RSD < 2.58%) for AZIB and 93.3-99.3% (RSD < 2.45%) for MAZIB. The results confirmed that these impedimetric biosensors offer high sensitivity and performance for the determination of trace PAEs in aqueous samples.


Subject(s)
Diethylhexyl Phthalate , Phthalic Acids , Humans , Ferrosoferric Oxide , Esters/chemistry , Phthalic Acids/chemistry , Dibutyl Phthalate
3.
RSC Adv ; 11(52): 32630-32646, 2021 Oct 04.
Article in English | MEDLINE | ID: mdl-35493596

ABSTRACT

In this work, a sensitive and efficient voltammetric biosensor was introduced for differential pulse voltammetric (DPV) determination of some phthalic acid esters (PAEs) including dibutyl phthalate (DBP), dimethyl phthalate (DMP), di(2-ethylhexyl)phthalate (DEHP) and dicyclohexyl phthalate (DCHP) in aqueous solutions. Briefly, the surface of a copper electrode was modified by azolla paste prepared using azolla powder and electroencephalography gel (EEG). The modified surface was characterized by electrochemical impedance spectroscopy (EIS), field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FT-IR), Brunauer-Emmett-Teller (BET) analysis and energy dispersive X-ray (EDX) methods. Determination of PAEs was conducted based on their blocking effect on the electrode surface for ferrous ion oxidation. The central composite design (CCD) was conducted to optimize the effects of four experimental parameters including the concentration of Fe2+ ions (C Fe2+ ) and supporting electrolyte (C sup. elec), solution pH and modifier/gel mass ratio on the decrease in the anodic peak current of ferrous ions as the response. Predicted optimal conditions (C Fe2+ = 319 µM, C sup. elec= 0.125 M, pH = 7.52 and modifier/gel mass ratio = 0.19) were validated by experimental checking which resulted in an error of 1.453%. At the optimum conditions, linear relationships were found between the DPV responses and PAEs concentrations and the limit of detection (LOD) and limit of quantification (LOQ) values were in the ranges of 0.2-0.4 µg L-1 and 0.5-1.0 µg L-1, respectively. Good recovery percentages ranging from 97.3 to 100.3% with RSD < 3.2% suggested the proposed method for efficient, accurate and quick determination of PAEs in real water samples.

4.
Glob J Health Sci ; 7(6): 108-16, 2015 Apr 03.
Article in English | MEDLINE | ID: mdl-26153168

ABSTRACT

BACKGROUND: Vulvovaginal candidiasis is known as one of the most common fungal infection among women of reproductive age and considered as an important public health problem. In recent years, due to resistance to common antifungal medication, the use of traditional medicine of anti-fungal and herbal treatment increased. Therefore the objective of this study was to determine the effects of vaginal cream, mixture of yogurt and honey and comparing it with clotrimazole vaginal cream on symptoms of Vulvovaginal candidiasis in patients. METHODS: In this randomized, triple blind clinical trial of 70 non-pregnant women infected with Candidal vulvovaginitis were placed in two groups of Vaginal cream mixed of yogurt and honey recipients (N=35) and clotrimazole vaginal cream (N=35). Both groups were treated for 7 days. At the beginning of study, Clinical and laboratory signs and symptoms were registered 7 and 14 days after treatment by questionnaire, observation form and secretions culture results. Data by chi-square test, t test, McNemar tests were analyzed by SPSS version 21. Significance level of 0.05 was considered. RESULTS: The result of present study reveals the significant differences in symptom improvement of ' yogurt and honey, than clotrimazole group (P<0.05) and also Positive results of the first cultures (one week after treatment) in "yogurt and honey" and clotrimazole (20% versus 8.6%) and second time cultivation (14 days after treatment) (17/1% versus 8.6%) were similar and there was no significant differences between the two groups. (P>0.05) CONCLUSION: This study indicated that he therapeutic effects of vaginal cream, yogurt and honey is not only similar with clotrimazole vaginal cream but more effective in relieving some symptoms of vaginal candidiasis. Therefore, the use of this product can be suggested as an herbal remedy for candida infection treatment.


Subject(s)
Antifungal Agents/therapeutic use , Candidiasis, Vulvovaginal/drug therapy , Clotrimazole/therapeutic use , Honey , Vaginal Creams, Foams, and Jellies/therapeutic use , Yogurt , Adult , Female , Humans , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...